ES8700053A1 - Procedimiento de obtencion de una composicion para el trata-miento de infecciones virales - Google Patents

Procedimiento de obtencion de una composicion para el trata-miento de infecciones virales

Info

Publication number
ES8700053A1
ES8700053A1 ES541103A ES541103A ES8700053A1 ES 8700053 A1 ES8700053 A1 ES 8700053A1 ES 541103 A ES541103 A ES 541103A ES 541103 A ES541103 A ES 541103A ES 8700053 A1 ES8700053 A1 ES 8700053A1
Authority
ES
Spain
Prior art keywords
pharmaceutical preparations
antiviral pharmaceutical
lidocaine
mammals
humans
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES541103A
Other languages
English (en)
Other versions
ES541103A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BRIGHAM DANA
Original Assignee
BRIGHAM DANA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BRIGHAM DANA filed Critical BRIGHAM DANA
Publication of ES8700053A1 publication Critical patent/ES8700053A1/es
Publication of ES541103A0 publication Critical patent/ES541103A0/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE COMPOSICIONES PARA EL TRATAMIENTO DE INFECCIONES VIRALES DEL GRUPO HERPES. COMPRENDE LAS SIGUIENTES ETAPAS: A) MEZCLAR A TEMPERATURA AMBIENTE LIDOCAINA O UNA SAL FARMACEUTICAMENTE ACEPTABLE DE LA MISMA (COMO HIDROHALURO, SULFATO, NITRATO, FOSFATO, ACETATO, TARTRATO, CITRATO, FUMARATO, MALEATO, TOLUENSULFONATO O METANOSULFONATO, PREFERENTEMENTE EN FORMA DE HIDROCLORURO) A UNA CONCENTRACION DE 1,5 A 10%, CON PANTENOL, ACIDO PANTOTENICO O SUS SALES FARMACEUTICAMENTE ACEPTABLES, A CONCENTRACIONES DE 5 A 50 MG/ML; Y B) PONER EN CONTACTO LA MEZCLA RESULTANTE, A TEMPERATURA AMBIENTE CON UN VEHICULO PARA APLICACION TOPICA O PARA INYECCIONE
ES541103A 1984-03-08 1985-03-08 Procedimiento de obtencion de una composicion para el trata-miento de infecciones virales Expired ES8700053A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/587,398 US4628063A (en) 1984-03-08 1984-03-08 Antiviral pharmaceutical preparations and methods for their use

Publications (2)

Publication Number Publication Date
ES8700053A1 true ES8700053A1 (es) 1986-10-16
ES541103A0 ES541103A0 (es) 1986-10-16

Family

ID=24349633

Family Applications (1)

Application Number Title Priority Date Filing Date
ES541103A Expired ES8700053A1 (es) 1984-03-08 1985-03-08 Procedimiento de obtencion de una composicion para el trata-miento de infecciones virales

Country Status (13)

Country Link
US (2) US4628063A (es)
EP (1) EP0154344B1 (es)
JP (1) JPH0676317B2 (es)
AT (1) ATE91233T1 (es)
AU (1) AU571072B2 (es)
DE (1) DE3587434T2 (es)
ES (1) ES8700053A1 (es)
IE (1) IE61525B1 (es)
IL (1) IL74535A (es)
NZ (1) NZ211361A (es)
PT (1) PT80079B (es)
WO (1) WO1985003862A1 (es)
ZA (1) ZA851765B (es)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380754A (en) * 1988-02-29 1995-01-10 Virotex Corporation Topical composition enhancing healing of viral lesions
US5055296A (en) * 1988-08-04 1991-10-08 Wagle Sudhakar S Method of treating chronic fatigue syndrome
US5284664A (en) * 1988-08-04 1994-02-08 Kremers-Urban Company Method of treating the symptoms of Alzheimer's disease
US5316775A (en) * 1988-08-04 1994-05-31 Kremers-Urban Company Method of treating hepatitis B infection
US5334395A (en) * 1988-08-04 1994-08-02 Kremers-Urban Company Method of treating an epstein-barr viral infection
SE8804214L (sv) * 1988-11-22 1990-05-23 Jean Cassuto Antiinflammatoriskt och antiinfektioest medikament
US4997853A (en) * 1988-12-02 1991-03-05 Galenpharma, Inc. Method and compositions utilizing capsaicin as an external analgesic
US5331012A (en) * 1990-07-30 1994-07-19 Riddick Kenneth B Topical pharmaceutical preparation for fever blisters and other viral infections and method of use
GB9027433D0 (en) * 1990-12-18 1991-02-06 Merrell Dow Pharma Anti-herpes castanospermine esters
JP3115625B2 (ja) * 1991-03-30 2000-12-11 帝國製薬株式会社 リドカイン含有外用貼付剤
HU212426B (en) * 1992-07-22 1996-06-28 Vepex Kft Process for producing bioactive pharmaceutical compositions
EP0643964A3 (en) * 1993-08-18 1995-08-09 Medipharma Sa Use of local anesthetics for the manufacture of a medicament for protecting the membranes of plasma cells.
CA2130291A1 (en) * 1993-08-18 1995-02-19 Juan Carlos Mahiques Therapeutic uses of known ester and amide compounds
US5506236A (en) * 1994-04-28 1996-04-09 Schering Corporation 4-substituted pyrazoloquinoline derivatives
US5776859A (en) * 1995-11-15 1998-07-07 Nickel; Alfred A. Sodium channel active novel compounds and related processes and bioassay techniques
US5869446A (en) * 1996-07-09 1999-02-09 Gambit International Limited Preparation of lactoferrin (or serotransferrin or ovotransferrin) and desferrioxamine methanesulfonate (or other low molecular weight metal ion chelators) for the therapy of viral infections
DE19823319A1 (de) * 1998-05-26 1999-12-02 Karl Engelhard, Fabrik Pharm.- Praeparate Gmbh & Co. Kg Topisch anwendbares Arzneimittel zur Behandlung von Virusinfektionen
US6093417A (en) * 1999-01-11 2000-07-25 Advanced Medical Instruments Composition to treat ear disorders
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US20040076671A1 (en) * 2002-10-21 2004-04-22 Aletha Tippett Methods and compositions for topical wound treatment
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
MXPA05004278A (es) 2002-10-25 2005-10-05 Foamix Ltd Espuma cosmetica y farmaceutica.
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
AU2006313443A1 (en) 2005-05-09 2007-05-18 Foamix Ltd. Foamable vehicle and pharmaceutical compositions thereof
ITRM20060163A1 (it) * 2006-03-24 2007-09-25 Ist Farmacoterapico It Spa Composizione spray ad uso topico per il tratamento e la prevenzione delle infezioni labiali da herpes simplex
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
CA2712120A1 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
CA2776474C (en) 2009-10-02 2021-01-12 Foamix Ltd. Topical tetracycline compositions
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
MX2020012139A (es) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Composiciones y metodos para tratar rosacea y acne.
RU2634264C1 (ru) * 2016-09-19 2017-10-24 Александр Ливиевич Ураков Крем-молочко для лечения опоясывающего лишая
IT201800007009A1 (it) * 2018-07-06 2020-01-06 Nuovo uso medico di anestetici locali

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1315727A (fr) * 1961-06-13 1963-01-25 Perfectionnement aux véhicules-jouets
RO75309A2 (ro) * 1978-10-24 1981-12-25 Intreprinderea De Antibiotice,Ro Unguent medicamentos pentru tratamentul zonei zoster
FR2484257A1 (fr) * 1980-06-16 1981-12-18 Girard Michele Composition polyvitaminee pour le traitement de l'herpes

Also Published As

Publication number Publication date
AU4067385A (en) 1985-09-24
ATE91233T1 (de) 1993-07-15
ZA851765B (en) 1985-11-27
NZ211361A (en) 1988-07-28
WO1985003862A1 (en) 1985-09-12
DE3587434D1 (de) 1993-08-12
EP0154344A3 (en) 1990-06-13
IL74535A0 (en) 1985-06-30
EP0154344B1 (en) 1993-07-07
JPH0676317B2 (ja) 1994-09-28
JPS61501325A (ja) 1986-07-03
PT80079A (en) 1985-04-01
IE850581L (en) 1985-09-08
PT80079B (pt) 1987-09-18
DE3587434T2 (de) 1994-02-17
IL74535A (en) 1988-12-30
AU571072B2 (en) 1988-03-31
US4628063A (en) 1986-12-09
EP0154344A2 (en) 1985-09-11
ES541103A0 (es) 1986-10-16
IE61525B1 (en) 1994-11-16
US4757088A (en) 1988-07-12

Similar Documents

Publication Publication Date Title
ES8700053A1 (es) Procedimiento de obtencion de una composicion para el trata-miento de infecciones virales
ES8801303A1 (es) Un procedimiento para preparar una formulacion farmaceutica que contiene un 2'3'-didesoxi-nucleosido.
AR240251A1 (es) Metodo para preparar una composicion para tratamiento de infecciones virales y un metodo para sintetizar 3' azido 2', 3' dideoxiuridina destinada a la preparacion de dicha composicion.
UA66744C2 (en) 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections
DK0973735T3 (da) Polyaromatiske antivirale præparater
DE3370587D1 (en) Compositions comprising interferon and their therapeutic use
DK326586D0 (da) Antivirale pyrimidinforbindelser, farmaceutiske kompositioner indeholdende forbindelserne og kompositionernes fremstilling
MY106231A (en) Antiviral tetrahydroimidazo [1,4] benzodiazepin-2- thiones.
DE3473272D1 (en) Guanine derivatives, compositions containing them, and their anti-viral use
MY104942A (en) Antiviral tetrahydroimidazo [1,4] benzodiazepin-2-ones.
DE3685484D1 (es)
AU8447991A (en) Antineoplastic effect potentiator and antineoplastic agent
HUP9900945A2 (hu) Nukleozidanalógok herpes simplex vírus fertőzések kombinációs terápiájában
CA2255856A1 (en) Therapeutic uses for an aminosterol compound
EP0531341A4 (en) Anti-viral therapy
ES2010559A6 (es) Procedimiento de preparacion de composiciones farmaceuticas antivirales de aplicacion externa que se acumulan en la piel.
DE3590054D2 (en) Therapeutic agent for combating infections caused by herpes viruses
ES481225A1 (es) Procedimiento para la preparacion de un medicamento con efecto antivirico que contiene acido ribonucleico de transferen-cia.
IL107818A (en) Pharmaceutical compositions for treating viral infections by conjunctive therapy with acylovir-like compounds and a 2'-(halo) methylene nucleoside analog
ES8800597A1 (es) Procedimiento para la preparacion de una composicion farmaceutica a base de 3-aminopropoxiindoles
EP0400312A3 (en) Method and composition for treating protozoal infections with a novel antibacterial agent
AU1575688A (en) Medicinal composition for treating and preventing diseases caused by cytotoxicity by cellular mediation, incorporating at least one pyridine derivate as active principle
GB2125700A (en) Anti-viral treatment method

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19990503